Product And Geographic Information

9 Months Ended

Sep. 27, 2014

Geographic Areas, Revenues from External Customers and Long-Lived Assets [Abstract]

Product And Geographic Information

PRODUCT AND GEOGRAPHIC INFORMATION

Segment Information

On January 28, 2014, the Company announced further organizational changes to combine its Implantable Electronic Systems Division and Cardiovascular and Ablation Technologies Division, resulting in an integrated research and development organization and a consolidation of manufacturing and supply chain operations worldwide. The integration has been conducted in a phased approach during 2014. The Company's continuing global realignment efforts are focused on streamlining its organization to improve productivity, reduce costs and leverage its scale to drive additional growth. During the third quarter of 2014, the Company changed the information regularly reviewed by its Chief Executive Officer, whom the Company has determined to be its Chief Operating Decision Maker, such that it now operates as a single operating segment and derives its revenues from six principal product categories.

The Company's six principal product categories are as follows: tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker (pacemaker) systems, atrial fibrillation (AF) products (electrophysiology (EP) introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories), structural heart products (heart valve replacement and repair products and structural heart defect devices) and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation devices). The Company generates its revenues from the sale of products it develops, manufactures, markets and/or distributes globally. The Company had no individual customer that represented 10 percent or more of its consolidated revenues for the three and nine months ended September 27, 2014 and September 28, 2013.

Product Information

The following table presents net sales from external customers for the Company's six major product categories (in millions):

	Three Months Ended				Nine Months Ended
Net Sales	September 27, 2014		September 28, 2013		September 27, 2014		September 28, 2013
ICD systems	$	422	$	418	$	1,320	$	1,299
Pacemaker systems	266		264		788		779
Atrial fibrillation products	253		235		761		705
Vascular products	169		168		521		521
Structural heart products	155		149		480		464
Neuromodulation products	107		104		313		311
	$	1,372	$	1,338	$	4,183	$	4,079

Geographic Information

The following table presents net sales by significant country based on customer location (in millions):

	Three Months Ended				Nine Months Ended
Net Sales	September 27, 2014		September 28, 2013		September 27, 2014		September 28, 2013
United States	$	666	$	646	$	1,979	$	1,955
Japan	132		142		398		418
Other foreign countries	574		550		1,806		1,706
	$	1,372	$	1,338	$	4,183	$	4,079

The amounts for long-lived assets by significant geographic market include net property, plant and equipment by physical location of the asset as follows (in millions):

Long-Lived Assets	September 27, 2014		December 28, 2013
United States	$	1,012	$	1,045
Other foreign countries	348		365
	$	1,360	$	1,410